Literature DB >> 3261251

Partial characterization of a novel stromal cell-derived pre-B-cell growth factor active on normal and immortalized pre-B cells.

F M Lemoine1, R K Humphries, S D Abraham, G Krystal, C J Eaves.   

Abstract

Characterization of three stromal cell lines that support the proliferation of murine pre-B cells showed that they all exhibit a fibroblast-like morphology, but express laminin and collagen type IV, and behave as pre-adipocytes. One of these lines was used as a feeder for the isolation of feeder-dependent (A8 cells) and feeder-independent (H9 cells) pre-B-cell subclones present in a spontaneously immortalized line of pre-B cells that originally arose in a long-term lymphoid marrow culture. Both pre-B subclones show the same JH gene rearrangement and are strongly BP-1 positive but differ from most pre-B-cell lines described to date in that they do not express immunoglobulin (Ig), B220, or T200. Cell density experiments confirmed that A8 cells do not proliferate (or survive) in the absence of an appropriate feeder layer when cultured alone at concentrations less than 10(5) cells/ml, but greater than 10(5) cells/ml can undergo a short-lived burst of proliferation. In contrast, H9 cells are readily maintained as an autonomous line at concentrations greater than 10(4) cells/ml, but their growth is suboptimal in the absence of stromal cells at lower concentrations, and at less than 3000 cells/ml, their ability to proliferate ceases. Additional experiments demonstrated that at least part of the supportive function of the stromal cells is due to their ability to produce a low molecular weight, heat-resistant factor that is active on normal pre-B cells as well as both A8 and H9 cells, and appears to be different from any previously described hemopoietic growth factor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3261251

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  11 in total

1.  Ex vivo expansion of hematopoietic progenitor cells is associated with downregulation of alpha4 integrin- and CXCR4-mediated engraftment in NOD/SCID beta2-microglobulin-null mice.

Authors:  Jacques Foguenne; Ivano Di Stefano; Olivier Giet; Yves Beguin; André Gothot
Journal:  Haematologica       Date:  2009-01-14       Impact factor: 9.941

2.  Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells.

Authors:  G Sauvageau; P M Lansdorp; C J Eaves; D E Hogge; W H Dragowska; D S Reid; C Largman; H J Lawrence; R K Humphries
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

3.  Chromatin immunoselection defines a TAL-1 target gene.

Authors:  S Cohen-Kaminsky; L Maouche-Chrétien; L Vitelli; M A Vinit; I Blanchard; M Yamamoto; C Peschle; P H Roméo
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

4.  Ameloblastin upstream region contains structural elements regulating transcriptional activity in a stromal cell line derived from bone marrow.

Authors:  Margareth V Tamburstuen; Malcolm L Snead; Janne E Reseland; Michael L Paine; Staale P Lyngstadaas
Journal:  Eur J Oral Sci       Date:  2011-12       Impact factor: 2.612

5.  Selective growth of freshly isolated human breast epithelial cells cultured at low concentrations in the presence or absence of bone marrow cells.

Authors:  J T Emerman; J Stingl; A Petersen; E J Shpall; C J Eaves
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

6.  Retroviral gene transfer to primitive normal and leukemic hematopoietic cells using clinically applicable procedures.

Authors:  P F Hughes; J D Thacker; D Hogge; H J Sutherland; T E Thomas; P M Lansdorp; C J Eaves; R K Humphries
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

7.  Wnt pathway contributes to the protection by bone marrow stromal cells of acute lymphoblastic leukemia cells and is a potential therapeutic target.

Authors:  Yang Yang; Saradhi Mallampati; Baohua Sun; Jing Zhang; Sang-Bae Kim; Ju-Seog Lee; Yun Gong; Zhen Cai; Xiaoping Sun
Journal:  Cancer Lett       Date:  2013-01-16       Impact factor: 8.679

8.  Chaetocin antileukemia activity against chronic myelogenous leukemia cells is potentiated by bone marrow stromal factors and overcomes innate imatinib resistance.

Authors:  L Truitt; C Hutchinson; J F DeCoteau; C R Geyer
Journal:  Oncogenesis       Date:  2014-10-20       Impact factor: 7.485

9.  Resolving the titer of murine cytomegalovirus by plaque assay using the M2-10B4 cell line and a low viscosity overlay.

Authors:  Katherine A Zurbach; Toktam Moghbeli; Christopher M Snyder
Journal:  Virol J       Date:  2014-04-18       Impact factor: 4.099

10.  RGDS-Modified Superporous Poly(2-Hydroxyethyl Methacrylate)-Based Scaffolds as 3D In Vitro Leukemia Model.

Authors:  Hana Svozilová; Zdeněk Plichta; Vladimír Proks; Radana Studená; Jiří Baloun; Michael Doubek; Šárka Pospíšilová; Daniel Horák
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.